Evidence map›Paper›PMID 35460632›Full record

GuidelineKidney international2022

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

KDIGO Conference Participants

Open access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in Kidney international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
23.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Genes & diseases · 2027
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetic Testing in the Management of Adult CKD.Journal of the American Society of Nephrology : JASN · 2026
    Article
  14. Article
  15. A PartialKidney medicine · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Genetic testing in chronic kidney disease of uneXplained cause (CKDx): clinical insights and evolving diagnostic paradigms.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 20 institutions in 15 countries.

KDIGO Conference Participants
Columbia University Irving Medical Center · USUniversity of Freiburg · DEColumbia University · USMassachusetts General Hospital · USUniversity of Melbourne · AUAlport Syndrome Foundation · USAmerican Journal Experts (United States) · USBaylor College of Medicine · USBeth Israel Deaconess Medical Center · USBoston Children's Hospital · USBroad Institute · USChildren's National · USCleveland Clinic Lerner College of Medicine · USCliniques Universitaires Saint-Luc · BEDirectorate-General Joint Research Centre · BEDuke Medical Center · USFrederick National Laboratory for Cancer Research · USGdańsk Medical University · PLGreat Ormond Street Hospital for Children NHS Foundation Trust · GBHôpital Necker-Enfants Malades · FR

Funding

Leveraging ancestry to map kidney lociR01MD012765 · NIMHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRANCESCHINI, NORA · 2017 to 2021
$3.6M
Genetics of kidney disease in diverse populationsR01DK117445 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRANCESCHINI, NORA · 2018 to 2022
$2.7M
Genetics of Cardiovascular Disease in Chronic Kidney DiseaseR01HL163972 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRANCESCHINI, NORA, LI, YUN · 2022 to 2025
$1.9M
Advancing equitable implementation of genomic medicine in nephrologyK01DK132495 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Hila Milo Rasouly · 2022 to 2026
$722k
Genetics of CKD and Hypertension-Risk Prediction and Drug Response in the MVPI01CX001897 · VA · VETERANS HEALTH ADMINISTRATION · PI Adriana Hung · 2020 to 2026
–
CSRD VA I01 CX001897NHLBI NIH HHS R01 HL163972NIDDK NIH HHS K01 DK132495NIDDK NIH HHS R01 DK117445NIMHD NIH HHS R01 MD012765
6 · The paper itself

Abstract

Numerous genes for monogenic kidney diseases with classical patterns of inheritance, as well as genes for complex kidney diseases that manifest in combination with environmental factors, have been discovered. Genetic findings are increasingly used to inform clinical management of nephropathies, and have led to improved diagnostics, disease surveillance, choice of therapy, and family counseling. All of these steps rely on accurate interpretation of genetic data, which can be outpaced by current rates of data collection. In March of 2021, Kidney Diseases: Improving Global Outcomes (KDIGO) held a Controversies Conference on "Genetics in Chronic Kidney Disease (CKD)" to review the current state of understanding of monogenic and complex (polygenic) kidney diseases, processes for applying genetic findings in clinical medicine, and use of genomics for defining and stratifying CKD. Given the important contribution of genetic variants to CKD, practitioners with CKD patients are advised to "think genetic," which specifically involves obtaining a family history, collecting detailed information on age of CKD onset, performing clinical examination for extrarenal symptoms, and considering genetic testing. To improve the use of genetics in nephrology, meeting participants advised developing an advanced training or subspecialty track for nephrologists, crafting guidelines for testing and treatment, and educating patients, students, and practitioners. Key areas of future research, including clinical interpretation of genome variation, electronic phenotyping, global representation, kidney-specific molecular data, polygenic scores, translational epidemiology, and open data resources, were also identified.

Indexed as

Renal Insufficiency, ChronicCongresses as TopicHumansNephrologygenetic kidney diseasegenetic testinggenome-wide association studiesmonogenicpolygenicsingle-nucleotide polymorphism

Identifiers

PMID35460632
PMCPMC9922534
OpenAlexW4224243429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.